ACA insurers get 3 extra weeks to file final rates for 2018

CMS has pushed back the deadline for insurers to file their final 2018 rate requests for the Affordable Care Act (ACA) exchanges until Sept. 5, giving companies extra time to decide what plans and prices to offer.

This deadline applies only to plans sold in the 39 states which rely on the federal Healthcare.gov exchange. The final deadline for insurers to sign contracts to participate in ACA markets, however, will remain the same: Sept. 27, ahead of beginning of open enrollment on Nov. 1.

The same memo from CMS offered no new guarantees on the cost-sharing reduction (CSR) subsidies. Those have continued to be paid out on a month-to-month basis by the Trump administration, but the possibility of the subsidies being eliminated has been priced into initial rate requests. A Kaiser Family Foundation analysis found insurers are tacking on an additional 3 to 10 percent hike to their requests because of the uncertainty around CSRs, with the threat of the individual mandate not being enforced adding another 20 percent.

"At this time, there have been no changes regarding the Department of Health and Human Service's ability to make cost-sharing reduction payments to issuers," the memo stated.

Another analysis of how ending CSRs could affect the ACA marketplace is forthcoming, as the Congressional Budget Office has announced it will release a report on the possibility next week.

""
John Gregory, Senior Writer

John joined TriMed in 2016, focusing on healthcare policy and regulation. After graduating from Columbia College Chicago, he worked at FM News Chicago and Rivet News Radio, and worked on the state government and politics beat for the Illinois Radio Network. Outside of work, you may find him adding to his never-ending graphic novel collection.

Around the web

Stryker, a global medtech company based out of Michigan, has kicked off 2025 with a bit of excitement. The company says Inari’s peripheral vascular portfolio is highly complementary to its own neurovascular portfolio.

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Mark Isenberg, executive vice president of Zotec Partners, discusses key developments that will reshape the specialty this year.